サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1764873

北米の臓器保存ソリューション市場の2031年までの予測-地域別分析- 製品、用途、タイプ、エンドユーザー別

North America Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

出版日
ページ情報
英文 140 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
北米の臓器保存ソリューション市場の2031年までの予測-地域別分析- 製品、用途、タイプ、エンドユーザー別
出版日: 2025年04月17日
発行: The Insight Partners
ページ情報: 英文 140 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の臓器保存ソリューション市場は、2023年に1億2,323万9,050米ドルと評価され、2031年には2億2,611万8,820米ドルに達すると予測され、2024～2031年のCAGRは8.0%と推定されます。

臓器移植ニーズの高まりが北米の臓器保存ソリューション市場を後押し

いくつかの慢性疾患は、心臓、肺、肝臓、腎臓、その他の臓器の機能にダメージを与えることが知られています。食生活の乱れは腎臓や肝臓の病気の開発につながり、臓器不全を引き起こすこともあります。例えば、世界人口の約10％が慢性腎臓病の影響を受けています。米国保健社会福祉省によると、米国では7人に1人以上（15%以下、3万7,000人以下の成人）が慢性腎臓病にかかっていると推定されています。さらに、過度のアルコール摂取は肝硬変を引き起こし、肝移植の必要性をもたらします。SRTR（Scientific Registry of Transplant Recipients）の報告によると、心不全の治療が成功するかどうかにかかわらず、新たな心臓移植の対象となる候補者の数は増え続けています。COVID-19の流行は新規登録に何らかの影響を与えました。2018～2020年までプラトーが続き、2020年にはわずかに減少した（2019年の4,087人から2020年の4,000人へ）後、2021年には新規心不全症例数は4,373人に増加しました。移植手術は世界的に普及しています。2023年、全米臓器分与ネットワーク（United Network for Organ Sharing）は、米国における臓器移植件数が4万6,000件を超えたと報告し、2022年から8.7％以上の増加を記録しました。また、腎臓移植は史上初めて2万7,000件を超えました。臓器待機リストに載っている患者は一般的に末期臓器疾患を患っており、QOLに大きな影響を与え、人生の終わりに近づいていることを示している可能性があります。末期臓器不全の患者数の増加は、時宜を得た臓器移植の必要性を誘発します。移植技術の進歩により、現在ではより多くの人々が臓器移植の対象となっています。臓器保存液は、臓器の生存能力と機能を一定期間維持するために使用され、臓器の輸送とその後のレシピエントへの移植を可能にします。臓器移植の成功は、主に臓器保存、手術、免疫療法、術後ケアによって決まる。したがって、臓器移植の需要の高まりが、臓器保存ソリューション市場を成長へと導いています。

北米の臓器保存ソリューション市場概要

北米の臓器保存ソリューション市場は、米国、カナダ、メキシコに区分されます。技術的に先進的な製品やソリューションの採用が増加していること、臓器移植件数が急増していることが、この地域の臓器保存ソリューション市場に利益をもたらしている要因です。米国は世界最大の臓器保存ソリューション市場であり、推定・予測期間中は世界市場を独占すると見られています。米国市場の成長は、米国における慢性腎臓病（CKD）有病率の上昇と高齢者の増加に起因しています。National Chronic Kidney Disease fact sheetによると、米国では2021年に～37,000人が慢性腎臓病に罹患しています。

2024年6月、米国腎臓基金（American Kidney Fund, Inc.）は、最大3万7,000人の米国人が腎臓病に罹患し、～808,000人の米国人が腎不全に罹患していると報告しました。55万7,000人以上のアメリカ人が透析治療を受けています。腎臓病の有病率は上昇傾向にあり、現在アメリカ成人の7人に1人（14％）が罹患しています。2021年には、約13万5,000人のアメリカ人が新たに腎不全と診断されました。また、腎臓病に罹患している10人のうち9人は自分が腎臓病であることに気づいておらず、腎機能が著しく低下している人の3人に1人も自分が腎臓病であることに気づいていないです。さらに、同じ情報源によると、25万人以上のアメリカ人が腎臓移植を受けており、9万3,000人以上のアメリカ人が腎臓移植待機リストに載っています。2023年には、腎臓移植を受けたのはわずか2万7,332人で、そのうち6,290人は生体ドナーからのものでした。米国食品医薬品局（FDA）の承認件数の増加と同国における市場参入企業の存在が、米国の臓器保存ソリューション市場の成長を後押ししています。2022年4月、TransMedics Group, Inc.は、循環死（DCD）後のドナーからの臓器に使用できるOCS Heart Systemの市販前FDA承認を取得したと発表しました。OCS心臓システムは、循環死後臓器提供（DCD）心臓の生体外蘇生、機能モニタリング、心拍保存の臨床適応拡大で承認されました。このように、臓器移植のニーズの高まりが米国の臓器保存ソリューション市場を牽引しています。米国の臓器保存ソリューションメーカーは、臓器輸送に使用する機器を発売しています。2023年8月、臓器移植の主要企業であるパラゴニクス Technologiesは、次世代ドナー肺保存システム「BAROguard」のFDA認可を取得しました。このシステムは、パラゴニクスの先進的な低体温保存技術と、自動化された連続的かつ能動的な気道圧制御を組み合わせたものです。これにより、ドナーからレシピエント患者への移動中、ドナー肺の最適な温度範囲と臨床的に推奨される膨張圧範囲が確実に維持されます。この先進技術の斬新な組み合わせは、移植医療における標準治療の改善と再定義に対する同社の継続的なコミットメントを強化するものです。

北米の臓器保存ソリューション市場の収益と2031年までの予測（千米ドル）

北米の臓器保存ソリューション市場セグメンテーション

北米の臓器保存ソリューション市場は、製品、用途、タイプ、エンドユーザー、国に分類されます。

製品別では、北米の臓器保存液市場は、ウィスコンシン大学ソリューション、カストジオールHTK、パーファデックス、ハイポサーモゾール、その他に分類されます。2023年にはウィスコンシン大学セグメントが最大の市場シェアを占めています。

用途別では、北米の臓器保存ソリューション市場は、静的低温保存、低体温機械灌流、常温機械灌流、その他に区分されます。静的低温保存セグメントが2023年に最大の市場シェアを占めました。

タイプ別では、北米の臓器保存ソリューション市場は腎臓、肝臓、肺、心臓、その他に分類されます。腎臓セグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別に見ると、北米の臓器保存ソリューション市場は臓器移植センター、病院、専門クリニックに分類されます。臓器移植センターセグメントが2023年に最大の市場シェアを占めました。

国別では、北米の臓器保存ソリューション市場は米国、カナダ、メキシコに区分されます。2023年の北米の臓器保存ソリューション市場シェアは米国が独占しました。

Waters Medical Systems LLC、XVIVO Perfusion、TransMedics、OrganOx Limited、Paragonix Technologies, Inc、Dr. Franz Koehler Chemie GmbH、Accord Healthcare、21ST Century Medicine、Bridge to Life Ltd.などが北米の臓器保存ソリューション市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察
  • 市場の魅力

第3章 調査手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 北米の臓器保存ソリューション市場：主要市場力学

  • 市場促進要因
    • 臓器移植ニーズの高まり
    • 慢性疾患の有病率の増加
  • 市場抑制要因
    • 高額な臓器移植手術
    • 臓器の入手可能性の制限
  • 市場機会
    • 市場参入企業による戦略的取り組み
  • 今後の動向
    • 機械灌流技術へのシフト
  • 促進要因と抑制要因の影響

第5章 臓器保存ソリューション市場：北米の分析

  • 臓器保存ソリューション市場収益（2021～2031年）
  • 臓器保存ソリューション市場の予測分析

第6章 北米の臓器保存ソリューション市場分析-製品別

  • ウィスコンシン大学ソリューション
  • カストジオールHTK
  • パーファデックス
  • ハイポサーモゾール
  • その他

第7章 北米の臓器保存液市場分析-用途別

  • 静的低温保存
  • 低体温機械灌流
  • 常温機械灌流
  • その他

第8章 北米の臓器保存ソリューション市場分析-タイプ別

  • 腎臓
  • 肝臓
  • 肺
  • 心臓
  • その他

第9章 北米の臓器保存ソリューション市場分析-エンドユーザー別

  • 臓器移植センター
  • 病院
  • 専門クリニック

第10章 北米の臓器保存ソリューション市場：国別分析

    • 北米
      • 米国
      • カナダ
      • メキシコ

第11章 臓器保存ソリューション市場-産業情勢

  • イントロダクション
  • 臓器保存ソリューション市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • TransMedics
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • st Century Medicine
  • Bridge to Life Ltd

第13章 付録

図表

List Of Tables

  • Table 1. North America Organ Preservation Solution Market Segmentation
  • Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 7. North America: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
  • Table 8. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 9. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 10. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 11. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 12. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 13. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 14. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 15. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 16. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 17. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 18. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 19. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 20. Recent Organic Growth Strategies in Organ Preservation Solutions Market
  • Table 21. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 22. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

  • Figure 1. North America Organ Preservation Solution Market Segmentation, by Country
  • Figure 2. Organ Preservation Solution Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
  • Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
  • Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
  • Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
  • Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 26. North America Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
  • Figure 27. North America: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 28. United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 29. Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 30. Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 31. Growth Strategies in Organ Preservation Solutions Market
目次
Product Code: TIPRE00025778

The North America organ preservation solution market was valued at US$ 1,23,239.05 thousand in 2023 and is expected to reach US$ 2,26,118.82 thousand by 2031; it is estimated to register a CAGR of 8.0% from 2024 to 2031.

Rising Need for Organ Transplantation Fuels North America Organ Preservation Solution Market

Several chronic diseases are known to damage the functioning of the heart, lungs, liver, kidney, and other organs. A poor diet contributes to the development of renal and hepatic illnesses, which can also lead to organ failure. For instance, around 10% of the global population is impacted by chronic kidney disease. According to the US Department of Health & Human Services, more than 1 in 7 (i.e., ~15% or ~37 thousand adults) are estimated to have chronic kidney disease in the US. Further, excessive alcohol consumption leads to liver cirrhosis, resulting in the need for a liver transplant. The Scientific Registry of Transplant Recipients (SRTR) reports that irrespective of the success of medical treatments for heart failure, the number of candidates eligible for new heart transplants continues to rise. The COVID-19 pandemic had some impact on new listings. After a plateau from 2018 through 2020 and a slight decrease in 2020 (from 4,087 in 2019 to 4,000 in 2020), the number of new heart failure cases increased to 4,373 in 2021. Transplantation surgeries are becoming more common worldwide. In 2023, the United Network for Organ Sharing reported a record of more than 46,000 organ transplants in the US, marking an increase of over 8.7% from 2022. Additionally, the country crossed the mark of 27,000 kidney transplants for the first time in its history. Patients who are on the organ waiting list typically suffer from end-stage organ disease, which significantly affects their quality of life and may indicate that they are nearing the end of their life. The rising number of individuals with end-stage organ failure triggers the need for timely organ transplantation. Due to advancements in transplantation techniques, more such people are now eligible for organ transplants. Organ preservation solutions are used to maintain the viability and function of organs for a certain period, allowing for their transport and subsequent transplantation into a recipient. The success of organ transplantation is primarily determined by organ preservation, surgery, immunotherapy, and post-operative care. Thus, a rising demand for organ transplantation drives the organ preservation solution market toward growth.

North America Organ Preservation Solution Market Overview

The North America organ preservation solution market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging number of organ transplants are the factors benefiting the organ preservation solution market in this region. The US is the largest organ preservation solution market across the world and is estimated to dominate the global market during the forecast period. The US market growth is attributed to the rising chronic kidney diseases (CKD) prevalence and the increasing geriatric population in the US. According to the National Chronic Kidney Disease fact sheet, ~37 thousand people in the US were suffering from chronic kidney diseases in 2021.

In June 2024, the American Kidney Fund, Inc. reported that up to 37 thousand Americans have kidney disease, and ~808,000 Americans are affected by kidney failure. More than 557,000 Americans are undergoing dialysis treatment. The prevalence of kidney disease is rising and currently affects over 1 in 7 (or 14%) of American adults. In 2021, around 135,000 Americans were newly diagnosed with kidney failure. Also, 9 out of 10 people affected by kidney disease are unaware they have it, and 1 in 3 of people with severely reduced kidney function are also unaware they have kidney disease. Furthermore, as per the same source stated that more than 250,000 Americans have undergone kidney transplants, and there are over 93,000 Americans on the kidney transplant waiting list. In 2023, only 27,332 people received kidney transplants, with 6,290 of those from living donors. The rising number of approvals from the US Food and Drug Administration (FDA) and the presence of market players in the country boost the US organ preservation solution market growth. In April 2022, TransMedics Group, Inc. announced that it received premarket FDA approval for its OCS Heart System, which can be used with organs from donors after circulatory death (DCD). The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts. Thus, the rising need for organ transplantation drives the organ preservation solutions market in the US. Organ preservation solution manufacturers in the US launch devices used for organ transportation. In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system, BAROguard. The system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This ensures that an optimal temperature range and a clinically recommended inflation pressure range for donor lungs are maintained throughout the journey from the donor to the recipient patient. This novel combination of advanced technologies reinforces the company's ongoing commitment to improving and redefining the standard of care within transplant medicine.

North America Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the North America organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the North America organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the North America organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the North America organ preservation solution market is segmented into the US, Canada, and Mexico. The US dominated the North America organ preservation solution market share in 2023.

Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST Century Medicine, and Bridge to Life Ltd., are among the leading companies operating in the North America organ preservation solution market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Organ Preservation Solution Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Need for Organ Transplantation
    • 4.1.2 Increasing Prevalence of Chronic Diseases
  • 4.2 Market Restraints
    • 4.2.1 Expensive Organ Transplant Surgeries
    • 4.2.2 Limited Organ Availability
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Future Trends
    • 4.4.1 Shift Toward Machine Perfusion Technique
  • 4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - North America Analysis

  • 5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • 5.2 Organ Preservation Solution Market forecast Analysis

6. North America Organ Preservation Solution Market Analysis - by Product

  • 6.1 University of Wisconsin Solution
    • 6.1.1 Overview
    • 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.2 Custodiol HTK
    • 6.2.1 Overview
    • 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.3 Perfadex
    • 6.3.1 Overview
    • 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.4 HypoThermosol
    • 6.4.1 Overview
    • 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.5 Others
    • 6.5.1 Overview
    • 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. North America Organ Preservation Solution Market Analysis - by Application

  • 7.1 Static Cold Storage
    • 7.1.1 Overview
    • 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.2 Hypothermic Machine Perfusion
    • 7.2.1 Overview
    • 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.3 Normothermic Machine Perfusion
    • 7.3.1 Overview
    • 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. North America Organ Preservation Solution Market Analysis - by Type

  • 8.1 Kidneys
    • 8.1.1 Overview
    • 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.2 Liver
    • 8.2.1 Overview
    • 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.3 Lungs
    • 8.3.1 Overview
    • 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.4 Heart
    • 8.4.1 Overview
    • 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. North America Organ Preservation Solution Market Analysis - by End User

  • 9.1 Organ Transplant Centers
    • 9.1.1 Overview
    • 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.2 Hospitals
    • 9.2.1 Overview
    • 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. North America Organ Preservation Solution Market - Country Analysis

  • 10.1 North America Organ Preservation Solution Market Overview
    • 10.1.1 North America: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 10.1.1.1 North America: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
      • 10.1.1.2 United States: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.2.1 United States: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.2.2 United States: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.2.3 United States: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.2.4 United States: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.3 Canada: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.3.1 Canada: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.3.2 Canada: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.3.3 Canada: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.3.4 Canada: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.4 Mexico: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.4.1 Mexico: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.4.2 Mexico: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.4.3 Mexico: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.4.4 Mexico: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organ Preservation Solutions Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Waters Medical Systems LLC
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 XVIVO Perfusion
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 TransMedics
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 OrganOx Limited
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Paragonix Technologies, Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dr. Franz Koehler Chemie GmbH
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Accord Healthcare
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8st Century Medicine
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bridge to Life Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms